15.00
-0.07 (-0.46%)
| Penutupan Terdahulu | 15.07 |
| Buka | 15.42 |
| Jumlah Dagangan | 1,588,680 |
| Purata Dagangan (3B) | 877,569 |
| Modal Pasaran | 833,950,528 |
| Harga / Pendapatan (P/E TTM) | 13.39 |
| Harga / Jualan (P/S) | 2.81 |
| Harga / Buku (P/B) | 2.49 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Jul 2025 - 4 Aug 2025 |
| Margin Keuntungan | 17.92% |
| Margin Operasi (TTM) | -9.46% |
| EPS Cair (TTM) | 1.12 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 17.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 7.98% |
| Nisbah Semasa (MRQ) | 4.11 |
| Aliran Tunai Operasi (OCF TTM) | 26.78 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 29.89 M |
| Pulangan Atas Aset (ROA TTM) | -5.20% |
| Pulangan Atas Ekuiti (ROE TTM) | 19.54% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Menurun | Menurun |
| Diagnostics & Research (Global) | Menurun | Menurun | |
| Stok | CareDx, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 1.38 |
|
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company’s commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 3.12% |
| % Dimiliki oleh Institusi | 99.30% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Gagnon Securities Llc | 31 Dec 2024 | 1,431,196 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 40.00 (Stephens & Co., 166.67%) | Beli |
| Median | 26.00 (73.33%) | |
| Rendah | 25.00 (HC Wainwright & Co., 66.67%) | Pegang |
| Purata | 30.33 (102.20%) | |
| Jumlah | 2 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 15.99 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 05 May 2025 | 25.00 (66.67%) | Pegang | 15.17 |
| 03 Mar 2025 | 25.00 (66.67%) | Pegang | 21.13 | |
| Stephens & Co. | 05 May 2025 | 40.00 (166.67%) | Beli | 15.17 |
| Goldman Sachs | 17 Apr 2025 | 26.00 (73.33%) | Beli | 17.62 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 13 May 2025 | Pengumuman | CareDx to Participate in Upcoming Investor Conferences |
| 30 Apr 2025 | Pengumuman | CareDx Reports First Quarter 2025 Results |
| 29 Apr 2025 | Pengumuman | CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting |
| 24 Apr 2025 | Pengumuman | CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting |
| 21 Apr 2025 | Pengumuman | CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) |
| 08 Apr 2025 | Pengumuman | CareDx to Report First Quarter 2025 Financial Results |
| 11 Mar 2025 | Pengumuman | CareDx Launches Two Expanded Indications for AlloSure Testing Services |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |